These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 34950985

  • 21. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
    Suzuki T, Kurano T, Kanazawa T, Suzuki N.
    Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
    [Abstract] [Full Text] [Related]

  • 22. Microcrystalline cellulose from soybean hull as an excipient in solid dosage forms: Preparation, powder characterization, and tableting properties.
    Alamdari NE, Aksoy B, Babu RJ, Jiang Z.
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132298. PubMed ID: 38750863
    [Abstract] [Full Text] [Related]

  • 23. Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent.
    Late SG, Banga AK.
    AAPS PharmSciTech; 2010 Dec; 11(4):1627-35. PubMed ID: 21086083
    [Abstract] [Full Text] [Related]

  • 24. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S, De Beer T, Remon JP, Vervaet C.
    Int J Pharm; 2012 Jan 17; 422(1-2):310-7. PubMed ID: 22101283
    [Abstract] [Full Text] [Related]

  • 25. Effect of preparation method on properties of orally disintegrating tablets made by phase transition.
    Kuno Y, Kojima M, Ando S, Nakagami H.
    Int J Pharm; 2008 May 01; 355(1-2):87-92. PubMed ID: 18182258
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł, Kasperek R, Poleszak E.
    Polim Med; 2014 May 01; 44(4):231-5. PubMed ID: 25932904
    [Abstract] [Full Text] [Related]

  • 32. Development and Standardization of Moringa oleifera Leaves as a Natural Dietary Supplement.
    Ali MA, Yusof YA, Chin NL, Ibrahim MN, Muneer S.
    J Diet Suppl; 2019 May 01; 16(1):66-85. PubMed ID: 29469600
    [Abstract] [Full Text] [Related]

  • 33. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
    Järvinen K, Hoehe W, Järvinen M, Poutiainen S, Juuti M, Borchert S.
    Eur J Pharm Sci; 2013 Mar 12; 48(4-5):680-8. PubMed ID: 23313622
    [Abstract] [Full Text] [Related]

  • 34. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol.
    Sano S, Iwao Y, Noguchi S, Kimura S, Itai S.
    Int J Pharm; 2013 May 01; 448(1):132-41. PubMed ID: 23524122
    [Abstract] [Full Text] [Related]

  • 35. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
    Bejugam NK, Mutyam SK, Shankar GN.
    Drug Dev Ind Pharm; 2015 Feb 01; 41(2):333-41. PubMed ID: 24279424
    [Abstract] [Full Text] [Related]

  • 36. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats.
    Tawfeek HM, Faisal W, Soliman GM.
    Pharm Dev Technol; 2018 Jun 01; 23(5):496-503. PubMed ID: 28489472
    [Abstract] [Full Text] [Related]

  • 37. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
    Douroumis DD, Gryczke A, Schminke S.
    AAPS PharmSciTech; 2011 Mar 01; 12(1):141-51. PubMed ID: 21181510
    [Abstract] [Full Text] [Related]

  • 38. Exploring the performance-controlling tablet disintegration mechanisms for direct compression formulations.
    Maclean N, Walsh E, Soundaranathan M, Khadra I, Mann J, Williams H, Markl D.
    Int J Pharm; 2021 Apr 15; 599():120221. PubMed ID: 33540006
    [Abstract] [Full Text] [Related]

  • 39. Cinnamyl O-amine functionalized chitosan as a new excipient in direct compressed tablets with improved drug delivery.
    Ren G, Clancy C, Tamer TM, Schaller B, Walker GM, Collins MN.
    Int J Biol Macromol; 2019 Dec 01; 141():936-946. PubMed ID: 31487516
    [Abstract] [Full Text] [Related]

  • 40. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
    Asker AF, Saied KM, Abdel-Khalek MM.
    Pharmazie; 1975 Jul 01; 30(7):466-70. PubMed ID: 1178765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.